Evaluation Of A Financial Incentive To Improve The Use Of Preventive Medicines By People With Asthma
Funder
National Health and Medical Research Council
Funding Amount
$137,860.00
Summary
Rising costs are threatening the future viability of the Pharmaceutical Benefits Scheme. New approaches are needed to address this challenge, including developing financial incentives for consumers to use effective low cost medicines in preference to higher cost alternatives. This study will develop a consumer incentive for use of low cost asthma preventer medicines, model the economic effects of this and bring together stakeholders to examine the policy and practice changes needed to implement ....Rising costs are threatening the future viability of the Pharmaceutical Benefits Scheme. New approaches are needed to address this challenge, including developing financial incentives for consumers to use effective low cost medicines in preference to higher cost alternatives. This study will develop a consumer incentive for use of low cost asthma preventer medicines, model the economic effects of this and bring together stakeholders to examine the policy and practice changes needed to implement the incentive.Read moreRead less
Developing And Implementing Systems To Optimise Treatment, Care And Support Among People Diagnosed With HIV
Funder
National Health and Medical Research Council
Funding Amount
$1,021,439.00
Summary
Immediate treatment of people diagnosed with HIV infection has become a key public health intervention, based on recent evidence confirming treatment suppresses the virus to undetectable levels, and effectively eliminates the risk of transmission to sexual partners. Our partnership will identify and address barriers to accessing specialist HIV care and starting treatment among people recently diagnosed with HIV, and will contribute to Australia’s goal of ending HIV transmission by 2020.